Takeshi Morimoto
12 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization (NCT05347069) | Takeshi Morimoto | 2022-06-14 |
| Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer (NCT04724460) | Takeshi Morimoto | 2021-02-18 |
| GOREISAN for Heart Failure (GOREISAN-HF) Trial (NCT04691700) | Takeshi Morimoto | 2021-01-19 |
| Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study (NCT03895502) | Takeshi Morimoto | 2019-05-27 |
Track Takeshi Morimoto automatically
Every clearance here is in the API, with alerts when new ones post.